----

----

| DELAWARE                                                            |   | 13-3411148                                |
|---------------------------------------------------------------------|--------|-------------------------------------------|
| (State or Other Jurisdiction of Incorporation or Organization) |   | (I.R.S. Employer Identification No.) |

| Larger Accelerated Filer o |   | Accelerated Filer o       |   |
|----------------------------|--------|---------------------------|--------|
|                       |   |
| Non-Accelerated Filer o    |   | Small Reporting Company x |   |

----

----

| 1. | In the Notes to the Company's consolidated Financial Statements in the Form 10-K, Note 5 - Income Taxes on page F-18 of the Company's Form 10-K, "Less valuation allowance" under the column "Foreign" was reported to be $2,358,000, however, the correct number is $24,358,000. This typographical error did not affect any of the other figures reported in the financial statements of the Company. |
|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2. | In the Company's Form 10-K, the "Consolidated Statements of Operations and Comprehensive Loss for the Year Ended December 31, 2008" contained a typographical error related to the amount shown for "Discount related to beneficial conversion feature of Preferred Stock". The amount showed, as filed, was $0. The correct amount is ($2,147,000). This typographical error caused the "Net Loss to Common Shareholders," the"Comprehensive Income (Loss)" and "Basic and diluted loss per share" reported in the Form 10-K to be incorrectly stated as ($6,414,000), ($5,549,000) and ($0.00), respectively.  The correct amount of the "Net Loss to Common Shareholders," the "Comprehensive Income (Loss)" and "Basic and diluted loss per share" is $(8,561,000), $(7,696,000) and ($0.01), respectively. |
|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3. | The errors discussed in the prior paragraph caused the above noted figures to be incorrectly reported in two paragraphs of Item 7 "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the Form 10-K which are hereby replaced: |
|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4. | This Amendment No. 2 does not attempt to modify or update any other disclosures set forth in the Company's Form 10-K. Additionally, this Amendment No. 2 is as of the filing date of the Form 10-K and does not update or discuss any other Company developments subsequent to the date of the Form 10-K. |
|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

PART IV.

| ITEM 15. | EXHIBITS, FINANCIAL STATEMENT SCHEDULES |
|---------------|-----------------------------------------|

| 31.1 | Certification of Chief Executive Officer and Acting Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 +                                           |
|------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 32.1 | Certification of Chief Executive Officer and Acting Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 + |

----

|                     |                           |                  |   |                                                                                                                     |   |
|--------------------------|--------------------------------|-----------------------|--------|--------------------------------------------------------------------------------------------------------------------------|--------|
|                     | LITHIUM TECHNOLOGY CORPORATION |
|                     |                           |                  |   |
| Date: September 14, 2009 | BY:                            | /s/ Theo M.M. Kremers |   |
|                     |                           |                  |   | Theo M.M. Kremers, Chief Executive Officer(Principal Executive Officer & Principal Financial and Accounting Officer) |   |
|                     |                           |                  |   |

----